StocksMedium•5 November 2026•
1 min read
BioAge Labs Reports Wider-than-Expected Q3 Loss
Key Facts
1BioAge Labs reported a quarterly loss of $0.73 per share, wider than the Zacks Consensus Estimate of a loss of $0.68.
2The company's results declined compared to a year ago when it reported a loss of $0.56 per share.
BioAge Labs reported a quarterly loss of $0.73 per share for the third quarter of 2026. Zacks reported that the results were wider than the analyst consensus estimate of a $0.68 loss per share. This performance represents a deterioration from the prior year's quarter, when the company reported a loss of $0.56 per share.
BIOA closed at $5.95 on November 4, 2026, prior to the release of the financial results. During that trading session, the stock reached a high of $6.3 and a low of $5.74.